Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
87
NCT01835548
NT0102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
Phase: Phase 3
Role: Lead Sponsor
Start: Jul 31, 2013
Completion: Jul 31, 2014